Research  ·  The Oldest Biohacking

What Are Peptide Bioregulators?

Epitalon, Thymalin and the other "Khavinson peptides": where they came from, what the research shows, and where they stand with the FDA.

Peptide bioregulators are sold online as anti-aging supplements and "research peptides." The evidence behind them is thin, and nearly all of it comes from one research group.

Peptide bioregulators are tissue extracts or very short synthetic peptides (two to four amino acids) developed by the Russian gerontologist Vladimir Khavinson and colleagues from the 1970s onward.1,2 Almost all the research on them comes from cell, animal and small clinical studies by that same group, and the FDA, reviewing Epitalon in 2026, found no clinical safety studies.3 None of them is approved by the FDA, and their status for compounding in the United States is still unsettled.

This article explains what they are, what the studies do and don't show, and their regulatory status. It does not cover doses or sources, and it is not a recommendation to use them.

Part One

What peptide bioregulators are

Extracts and short synthetic peptides

They come in two kinds:1,3

Name What it is
Thymalin An extract of thymus gland
Epithalamin An extract of pineal gland
Cortexin An extract of brain cortex
Epitalon (Epithalon, AEDG) A synthetic four-amino-acid peptide, designed from Epithalamin
Vilon (KE) A synthetic two-amino-acid peptide

Epitalon and Epithalamin are often confused. The FDA treats them as different substances: Epithalamin is a gland extract, while Epitalon is a synthetic peptide.3

Origins. Khavinson trained at the Kirov Military Medical Academy in Leningrad and founded the St. Petersburg Institute of Bioregulation and Gerontology in 1992.2 By his own account, reported in the Russian press, the first products were developed in the 1970s at the request of the Soviet Ministry of Defense.4

Proposed mechanism. The developers propose that very short peptides enter the cell nucleus and bind histones and DNA, switching genes on or off.1 That review, written by the developers, has no methods section, and an independent 2025 review describes Epitalon's mechanism as uncertain.5

Part Two

What the research shows

Mostly cells and animals, from one group

  • Cells. In the developers' studies, Epitalon switched on telomerase, the enzyme that rebuilds the ends of chromosomes, and lengthened telomeres in human fetal cells; cells that had stopped dividing went through ten more divisions.6,7
  • The one independent replication. In 2025, researchers at Brunel University found Epitalon lengthened telomeres in normal human cell lines, and in two breast-cancer cell lines through a different mechanism. It was a cell-culture study, and a correction to its figures followed.8
  • Animals. In rodents, some preparations increased average lifespan by 20 to 40%, according to the developers.9
  • People. The developers reported that 266 people over 60 who received the thymus or pineal extracts had 1.6 to 4.1 times lower mortality over six to eight years. The published abstract does not describe randomization, blinding or how the comparison group was chosen, and the products were extracts, not synthetic Epitalon.10 A smaller study of 79 heart patients, also with Khavinson as an author, had no placebo group.11

When the FDA reviewed Epitalon in 2026, it noted that most studies were conducted and published by Khavinson's group, and it found no data on how the body handles the drug, no clinical safety studies and no long-term cancer studies.3 We found no registered clinical trials of these peptides on ClinicalTrials.gov.12 A Russian critic quoted in the press put it bluntly: "These peptides have never been studied in a normal comparative experiment."4

Part Three

Are peptide bioregulators legal in the U.S.?

Not approved, and unsettled for compounding

  • Not FDA-approved. No peptide bioregulator is an approved drug in the United States.3
  • Compounding. In 2023 the FDA placed Epitalon on its list of substances that may present significant safety risks in compounding. By 2026 it appeared on that page as "nominated but withdrawn."13 In May 2026 FDA staff recommended against allowing Epitalon in compounding;3 at a July 2026 meeting, the advisory committee narrowly voted the other way, for insomnia. The vote is not binding, and no rule had been issued at the time of writing.14,15
  • "Research use only" labels. In warning letters about other peptides, the FDA has said these labels don't stop products intended for people from being drugs, and that such products may be contaminated, counterfeit or contain varying amounts of the active ingredient.16
  • Supplements. Whether oral "bioregulator" supplements can legally be sold as dietary supplements depends on rules for new dietary ingredients, and we found no FDA decision on them.17
  • Russia. Thymalin and Cortexin are registered medicines in Russia.18 That registration does not meet U.S. standards.
  • Advertising. The Federal Trade Commission says health claims generally need randomized, controlled human trials, and that animal and laboratory studies are not enough on their own.19
Part Four

Safety and quality

Unknown long-term safety, and real quality risks

The long-term safety of these peptides in people is unknown. The absence of adverse-event reports to the FDA is not evidence of safety, which the agency itself points out, and the FDA has raised a specific concern: activating telomerase could, in principle, help cells avoid normal aging and become cancerous.3

Quality is a separate risk. In a Belgian study of falsified peptide drugs bought online, purity ranged from 5% to 75% for some products, with heavy metals far above the limits for injectable medicines.20 Belgian authorities have also found Epitalon in illegal preparations.21

Part Five

Quick answers

What are Khavinson peptides?

Tissue extracts and very short synthetic peptides, such as Thymalin, Epithalamin, Cortexin, Epitalon and Vilon, developed by the Russian gerontologist Vladimir Khavinson and his colleagues.

Is Epitalon the same as Epithalon or Epithalamin?

Epitalon and Epithalon are two spellings of the same synthetic peptide. Epithalamin is a different product: an extract of pineal gland.

Do peptide bioregulator supplements work?

Nobody knows. The research is almost all from cells, animals and small studies by the developers, with no independent large trials in people.

Is Epitalon safe?

Its long-term safety in people hasn't been studied. The FDA found no clinical safety studies, and products sold online can be impure or mislabeled.

Is Epitalon legal in the U.S.?

It is not an approved drug. Its status for compounding was still under review in 2026, and products labeled "research use only" are not approved for use in people.

Sources

  1. Khavinson VK, et al. Peptide regulation of gene expression: A systematic review. Molecules. 2021;26(22):7053. doi:10.3390/molecules26227053. PubMed
  2. Khavinson V. Curriculum vitae. khavinson.info
  3. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee briefing document: Epitalon-related bulk drug substances. May 2026. fda.gov
  4. Barkalova E. "Who is 'Putin's gerontologist' Vladimir Khavinson?" Bumaga, January 24, 2024. papernews.online
  5. Araj SK, et al. Overview of Epitalon: Highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences. 2025;26(6):2691. doi:10.3390/ijms26062691. PubMed
  6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;135(6):590–592. doi:10.1023/a:1025493705728. PubMed
  7. Khavinson VKh, et al. Peptide promotes overcoming of the division limit in human somatic cell. Bulletin of Experimental Biology and Medicine. 2004;137(5):503–506. doi:10.1023/b:bebm.0000038164.49947.8c. PubMed
  8. Al-Dulaimi S, et al. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26(5):178. doi:10.1007/s10522-025-10315-x. Correction: Biogerontology. 2025;27(1):1. doi:10.1007/s10522-025-10326-8. PubMed
  9. Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: Results and prospects. Biogerontology. 2010;11(2):139–149. doi:10.1007/s10522-009-9249-8. PubMed
  10. Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters. 2003;24(3–4):233–240. PubMed
  11. Korkushko OV, et al. Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: Results of 15-year follow-up. Bulletin of Experimental Biology and Medicine. 2011;151(3):366–369. doi:10.1007/s10517-011-1332-x. PubMed
  12. ClinicalTrials.gov. Searches for epitalon, epithalon, epithalamin, thymalin, cortexin and "Khavinson," October 13, 2026: no registered studies. clinicaltrials.gov
  13. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Current as of April 22, 2026. fda.gov
  14. U.S. Food and Drug Administration. July 23–24, 2026 Meeting of the Pharmacy Compounding Advisory Committee. fda.gov
  15. Healio. "FDA committee recommends looser restrictions for several peptides." September 2026. healio.com
  16. U.S. Food and Drug Administration. Warning letter to USApeptide.com, MARCS-CMS 696885, February 26, 2025. fda.gov
  17. 21 U.S.C. § 321(ff) (definition of dietary supplement) and § 350b (new dietary ingredients). law.cornell.edu
  18. Vidal (Russian drug reference). Thymalin and Cortexin. vidal.ru
  19. Federal Trade Commission. Health Products Compliance Guidance. December 2022. ftc.gov
  20. Janvier S, et al. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta. 2018;188:795–807. doi:10.1016/j.talanta.2018.06.023. PubMed
  21. Vanhee C, et al. Identification of the small research tetra peptide Epitalon, assumed to be a potential treatment for cancer, old age and retinitis pigmentosa in two illegal pharmaceutical preparations. Drug Testing and Analysis. 2015;7(3):259–264. doi:10.1002/dta.1771. PubMed

This article is for education only and is not medical advice. See our Medical Disclaimer. Last reviewed October 13, 2026.

Research Worth Reading

New articles like this one, sent to you when they are published: what the evidence actually shows and what the classical texts actually say, in plain English. Join The Naturalist Archive and you will also hear first about Archive giveaways, and receive the English translation of Nam Dược Thần Hiệu free the day it is released.

Your first name is only used to greet you. Your email receives new research, Archive updates and the translation when it is released. For adults 18 and over. Unsubscribe anytime. See our privacy policy.